NCT00002147View on ClinicalTrials.gov

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Doxorubicin hydrochloride (liposomal)

Trial Locations (1)

94025

Sequus Pharmaceutical Inc, Menlo Park

All Listed Sponsors

lead

Sequus Pharmaceuticals

INDUSTRY